This week is the one-year anniversary of my first column with Hypoparathyroidism News! It’s been an incredible experience, and I’m so thankful to have been given the opportunity to share my rare disease journey. Looking back over the past 43 columns, I’m emotional at these snapshots of my life.
Entera Bio and Opko Health are teaming up to develop a once-daily oral treatment for hypoparathyroidism, known as a long-acting parathyroid hormone analog (LA-PTH). “Preclinical data of oral LA-PTH suggests that this program holds the potential to transform the hypoparathyroidism landscape,” Miranda Toledano, CEO of Entera, said…
Discussion
“The courage to soar to great heights is inside all of us.” — Olympic gold medalist Kerri Strug In sports, we discover one of life’s greatest lessons: the courage to overcome adversity and rise stronger each time we fall. Sports have the power to transform lives by teaching resilience and…
Discussion
Note: This column describes the experiences of a columnist and/or an interviewee with several therapies, including Yorvipath (palopegteriparatide), Calci-Chew (chewable calcium carbonate), One-Alpha (alfacalcidol), and Forteo (teriparatide). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. When I started my journey…
Get regular updates to your inbox.
